← Back to front page
United States · Markets & Finance · Quartz

Foghorn Therapeutics is cutting 40% of its workforce after Eli Lilly ends cancer drug partnership

Published by Quartz · United States 2 h ago

The companies are scrapping two collaborative cancer programs and don't anticipate any further joint projects

Read the full article on Quartz Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)

Also worth reading